CLPT — ClearPoint Neuro, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1285550 ·
Last close
$7.86
Market Cap
$251.95M
52W High
$19.63
52W Low
$7.81
ADV30
686,330
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 12,075,000 | 7,059,000 | -6,332,000 | -7,460,000 | 112,728,000 | 46,184,000 | 85,461,000 |
| Jun 2026 | 10,880,000 | 6,710,000 | -10,244,000 | -11,337,000 | 86,741,000 | 29,363,000 | 75,965,000 |
| Mar 2026 | 12,128,000 | 7,756,000 | -8,478,000 | -9,552,000 | 93,416,000 | 35,593,000 | 74,575,000 |
| Dec 2025 | 10,410,000 | 6,404,000 | -7,045,000 | -7,786,000 | 97,747,000 | 45,923,000 | 69,727,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-32,174,000
Investing CF
$92,000
Financing CF
$40,791,000
CapEx
$-1,045,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.15
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-245,259,000
Inventory
$9,772,000
Receivables
$8,017,000
ST Investments
—
EBIT TTM
$-30,008,000
Pretax Income TTM
$-36,165,000
Interest Exp TTM
$6,157,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,493,000
EBITDA
$-29,024,000
Free Cash Flow
$-15,280,000
Enterprise Value
$369,534,048
Total Cash
$46,184,000
Total Debt
$73,699,000
Shares Out
32,054,268
Trailing EPS
$-1.21
Book Value
$0.85
ROE
-167.5%
ROA
-21.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,971,000 | -24,164,000 | -25,540,000 | 97,747,000 | 69,727,000 | 28,020,000 | -23,925,000 |
| Dec 2024 | 31,390,000 | -19,734,000 | -18,914,000 | 39,189,000 | 13,800,000 | 25,389,000 | -8,950,000 |
| Dec 2023 | 23,955,000 | -22,446,000 | -22,089,000 | 42,661,000 | 21,488,000 | 21,173,000 | -13,720,000 |
| Dec 2022 | 20,551,000 | -16,332,000 | -16,435,000 | 55,490,000 | 18,603,000 | 36,887,000 | -16,167,000 |
TTM Snapshot
Revenues TTM
$42,279,000
NetIncome TTM
$-34,566,000
OpCashFlow TTM
—
Assets (Latest)
$86,741,000
Forward EPS
$-1.10
Max Pain — expiry 2027-01-15
max pain strike: $12.50 · spot: $7.71 · call oi: 1,537 · put oi: 974
Expected Move to 2027-01-15:
±$3.28
(42.54%) —
implied range
$4.43 –
$10.99
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZJYL | Jin Medical International Ltd. | $248.61M | $3.38 | — |
| PROF | Profound Medical Corp. | $259.32M | $7.08 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $242.36M | $3.51 | — |
| SSII | SS Innovations International, Inc. | $266.51M | $1.33 | — |
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
News headlines (Yahoo Finance, 1h cache)
ClearPoint Neuro, Inc. Q3 2026 Earnings Call Summary
2026-10-29 12:30 · Yahoo
ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript
2026-10-29 04:43 · Yahoo
What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call
2026-10-29 02:04 · Yahoo
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates
2026-10-28 22:30 · Yahoo
ClearPoint Neuro Reports Third Quarter 2026 Results
2026-10-28 20:05 · Yahoo
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
2026-10-14 20:05 · Yahoo
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
2026-09-29 13:30 · Yahoo
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
2026-09-04 12:14 · Yahoo
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
2026-08-11 01:48 · Yahoo
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
2026-08-03 22:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.